Mode
Text Size
Log in / Sign up
N/A Completed N=29 Randomized Single-blind Prevention

Texting for Mobility in Overweight/Obese Adults With Peripheral Artery Disease

Overweight and Obesity
Source: ClinicalTrials.gov NCT03694652 ↗
Enrolled (actual)
29
Serious AEs
0.0%
Results posted
May 2023
Primary outcomePrimary: Walking Distance — 331.19; 298.67 meters

Summary

By doing this study, researchers hope to learn about the feasibility of using a mobile application to help overweight or obese adults with PAD increase their walking distance and lose weight.

Outcome Measures

OutcomeResultp-value
PRIMARY
Walking Distance
331.19; 298.67
SECONDARY
Weight Loss
2.3; 10.1
SECONDARY
Quality of Life (QoL)
5.09; 5.36
SECONDARY
Physical Activity
22.73; 27.32
SECONDARY
Dietary Habits
2.61; 2.45

Eligibility Criteria

Inclusion Criteria

  • Overweight or obese (body mass index >=27 kg/m2)
  • Have symptomatic PAD
  • English speaking
  • Have 24 hour access to a cell phone

Exclusion Criteria

  • Cannot tolerate fruits and vegetables, fiber, and/or a low fat diet, as informed by a physician and/or registered dietician
  • Restricted intake of water
  • Pregnancy
  • Prior major amputation (foot or lower leg) or critical leg ischemia (tissue loss, gangrene, or ulcers)
  • Use of supplemental oxygen
  • Heart attack within preceding 3 months
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03694652). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search